Bristol-Myers 1st-quarter profit drops on lower drug sales, CEO's term extended

Bristol-Myers Squibb Co. said Thursday its first-quarter profit fell 3.4 percent on a drop in sales of several key drugs, but still beat Wall Street expectations.

Leave a Reply

Your email address will not be published. Required fields are marked *